Tag: Lupus nephritis

According to MyLupusTeam, weight gain is the most highly reported side effect of steroids by people with lupus. While not all treatments cause it, the question 'Does lupus medication make you gain weight?' is a significant concern for many patients navigating their treatment journey.

Up to 60% of people with systemic lupus erythematosus (SLE) will develop lupus nephritis, a serious kidney complication [1.8.1, 1.5.5]. For those prescribed Lupkynis, a key question is: **how long does it take for Lupkynis to work?** While it begins working immediately, noticeable results can take weeks to months [1.2.2, 1.2.3].

In late 2024 and early 2025, advanced cell therapy modalities like CAR-T therapy gained significant interest for autoimmune diseases like lupus. The emerging landscape provides new hope for those wondering, **What is the new treatment for lupus 2025?**, as a range of innovative therapies progress through clinical trials and regulatory review.

In 2021, the U.S. Food and Drug Administration (FDA) approved Voclosporin (Lupkynis), making it the first oral treatment specifically for lupus nephritis, a severe complication of systemic lupus erythematosus (SLE). This landmark approval significantly expanded the options for patients grappling with this debilitating autoimmune disease.

Mycophenolate mofetil was first approved by the U.S. FDA on May 3, 1995, primarily for preventing kidney transplant rejection. This guide explores the full range of uses for this powerful immunosuppressant, answering the key question: **what is mycophenolate used for?**

Approved by the FDA in January 2021, Lupkynis (voclosporin) is the first oral medication specifically developed to treat active lupus nephritis (LN) in adults. This targeted immunosuppressant is used in combination with other standard therapies to protect the kidneys from inflammation and damage.